Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


14 enero 2016

SPRINGER. CT angiography and CT perfusion improve prediction of infarct volume in patients with anterior circulation stroke

Tom van Seeters, Geert Jan Biessels, L. Jaap Kappelle, Irene C. van der Schaaf, Jan Willem Dankbaar, Alexander D. Horsch, Joris M. Niesten, Merel J. A. Luitse, Charles B. L. M. Majoie, Jan Albert Vos, Wouter J. Schonewille, Marianne A. A. van Walderveen, Marieke J. H. Wermer, Lucien E. M. Duijm, Koos Keizer, Joseph C. J. Bot, Marieke C. Visser, Aad van der Lugt, Diederik W. J. Dippel, F. Oskar H. W. Kesselring, Jeannette Hofmeijer, Geert J. Lycklama à Nijeholt, Jelis Boiten, Willem Jan van Rooij, Paul L. M. de Kort, Yvo B. W. E. M. Roos, Frederick J. A. Meijer, C. Constantijn Pleiter, Willem P. T. M. Mali, Yolanda van der Graaf, Birgitta K. Velthuis, on behalf of the Dutch acute stroke study (DUST) investigators

Introduction: We investigated whether baseline CT angiography (CTA) and CT perfusion (CTP) in acute ischemic stroke could improve prediction of infarct presence and infarct volume on follow-up imaging.

03 septiembre 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. Carotid Near-Occlusion: A Comprehensive Review, Part 2—Prognosis and Treatment, Pathophysiology, Confusions, and Areas for Improvement

E. Johansson and A.J. Fox

SUMMARY: In Part 1 of this review, the definition, terminology, and diagnosis of carotid near-occlusion were presented. Carotid near-occlusions (all types) showed a lower risk of stroke than other severe stenoses. However, emerging evidence suggests that the near-occlusion prognosis with full collapse (higher risk) differs from that without full collapse (lower risk). This systematic review presents what is known about carotid near-occlusion. In this second part, the foci are prognosis and treatment, pathophysiology, the current confusion about near-occlusion, and areas in need of future improvement.

08 octubre 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. Diagnostic Impact of Bone-Subtraction CT Angiography for Patients with Acute Subarachnoid Hemorrhage

P. Aulbach, D. Mucha, K. Engellandt, K. Hädrich, M. Kuhn and R. von Kummer

BACKGROUND AND PURPOSE: Detection and evaluation of ruptured aneurysms is critical for choosing an appropriate endovascular or neurosurgical intervention. Our aim was to assess whether bone-subtraction CTA is capable of guiding treatment for cerebral aneurysms in patients with acute SAH and could replace DSA.

08 octubre 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. Cerebral Perfusion Pressure is Maintained in Acute Intracerebral Hemorrhage: A CT Perfusion Study

A.S. Tamm, R. McCourt, B. Gould, M. Kate, J.C. Kosior, T. Jeerakathil, L.C. Gioia, D. Dowlatshahi, M.D. Hill, S.B. Coutts, A.M. Demchuk, B.H. Buck, D.J. Emery, A. Shuaib and K.S. Butcher on behalf of the ICH ADAPT Investigators

BACKGROUND AND PURPOSE: Although blood pressure reduction has been postulated to result in a fall in cerebral perfusion pressure in patients with intracerebral hemorrhage, the latter is rarely measured. We assessed regional cerebral perfusion pressure in patients with intracerebral hemorrhage by using CT perfusion source data.

22 octubre 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. Osseous Pseudoprogression in Vertebral Bodies Treated with Stereotactic Radiosurgery: A Secondary Analysis of Prospective Phase I/II Clinical Trials

B. Amini, C.B. Beaman, J.E. Madewell, P.K. Allen, L.D. Rhines, C.E. Tatsui, N.M. Tannir, J. Li, P.D. Brown and A.J. Ghia

BACKGROUND AND PURPOSE: Osseous pseudoprogression on MR imaging can mimic true progression in lesions treated with spine stereotactic radiosurgery. Our aim was to describe the prevalence and time course of osseous pseudoprogression to assist radiologists in the assessment of patients after spine stereotactic radiosurgery.

27 agosto 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. Carotid Near-Occlusion: A Comprehensive Review, Part 1—Definition, Terminology, and Diagnosis

E. Johansson and A.J. Fox

SUMMARY: Carotid near-occlusion is distal ICA luminal collapse beyond a tight stenosis, where the distal lumen should not be used for calculating percentage stenosis. Near-occlusion with full ICA collapse is well-known, with a threadlike lumen. However, near-occlusion without collapse is often subtle and can be overlooked as a usual severe stenosis. More than 10 different terms have been used to describe near-occlusion, sometimes causing confusion. This systematic review presents what is known about carotid near-occlusion. In this first part, the foci are definition, terminology, and diagnosis.

27 agosto 2015

AMERICAN JOURNAL OF NEURORADIOLOGY. A New Aneurysm Occlusion Classification after the Impact of Flow Modification

H.S. Cekirge and I. Saatci

SUMMARY: A new classification is proposed for cerebral aneurysms treated with any endovascular technique, for example, coiling with or without adjunctive devices, flow diversion, intrasaccular flow modifiers, or any combination of the above. Raymond-Roy Occlusion Classification is expanded with novel subgroups such as class 1 represents complete occlusion and is subdivided if a branch is integrated to, or originated from, the aneurysm sac; class 2 represents neck filling; class 3 represents incomplete occlusion with aneurysm filling as in the previous classification; and class 4 describes the immediate postoperative status after extra- or intrasaccular flow modification treatment. A new concept, “stable remodeling,” is included as class 5, which represents filling in the neck region that stays unchanged or reduced, as shown with at least 2 consecutive control angiographies, at least 6 months apart, for not <1 year, or the remodeled appearance of a dilated and/or tortuous vessel in continuation with the parent artery without sac filling.

30 octubre 2014

STROKE. Clinical Sciences. Influence of Age on Clinical and Revascularization Outcomes in the North American Solitaire Stent-Retriever Acute Stroke Registry

Alicia C. Castonguay, PhD; Osama O. Zaidat, MD, MS; Roberta Novakovic, MD; Thanh N. Nguyen, MD; M. Asif Taqi, MD; Rishi Gupta, MD; Chung-Huan J. Sun, MD; Coleman Martin, MD; William E. Holloway, MD; Nils Mueller-Kronast, MD; Joey E. English, MD; Italo Linfante, MD; Guilherme Dabus, MD; Tim W. Malisch, MD; Franklin A. Marden, MD; Hormozd Bozorgchami, MD; Andrew Xavier, MD; Ansaar T. Rai, MD; Michael T. Froehler, MD, PhD; Aamir Badruddin, MD; Michael G. Abraham, MD; Vallabh Janardhan, MD; Hashem Shaltoni, MD; Albert J. Yoo, MD; Alex Abou-Chebl, MD; Peng R. Chen, MD; Gavin W. Britz, MD; Ritesh Kaushal, MD; Ashish Nanda, MD; Mohammad A. Issa, MD; Raul G. Nogueira, MD

Background and Purpose: The Solitaire With the Intention for Thrombectomy (SWIFT) and thrombectomy revascularization of large vessel occlusions in acute ischemic stroke (TREVO 2) trial results demonstrated improved recanalization rates with mechanical thrombectomy; however, outcomes in the elderly population remain poorly understood. Here, we report the effect of age on clinical and angiographic outcome within the North American Solitaire-FR Stent-Retriever Acute Stroke (NASA) Registry.

28 octubre 2014

STROKE. Clinical Sciences. Time to Angiographic Reperfusion in Acute Ischemic Stroke

Achala S. Vagal, MD, MS; Pooja Khatri, MD, MSc; Joseph P. Broderick, MD; Thomas A. Tomsick, MD; Sharon D. Yeatts, PhD; Mark H. Eckman, MD, MS

Background and Purpose: Our objective was to use decision analytic modeling to compare 2 treatment strategies of intravenous recombinant tissue-type plasminogen activator (r-tPA) alone versus combined intravenous r-tPA/endovascular therapy in a subgroup of patients with large vessel (internal carotid artery terminus, M1, and M2) occlusion based on varying times to angiographic reperfusion and varying rates of reperfusion.

11 septiembre 2014

STROKE. Clinical Sciences. Picking the Good Apples. Statistics Versus Good Judgment in Choosing Stent Operators for a Multicenter Clinical Trial

George Howard, DrPH; Jenifer H. Voeks, PhD; James F. Meschia, MD; Virginia J. Howard, PhD; Thomas G. Brott, MD

Background and Purpose: The Carotid Revascularization Endarterectomy Versus Stenting Trial was completed with a low stroke and death rate. A lead-in series of patients receiving carotid artery stenting was used to select the physician-operators for the study, where performance was evaluated by complication rates and by peer review of cases. Herein, we assess the potential contribution of statistical evaluation of complication rates.

25 septiembre 2014

STROKE. Clinical Sciences. Genome-Wide Association Study of Intracranial Aneurysm Identifies a New Association on Chromosome 7

Tatiana Foroud, PhD; Dongbing Lai, MS; Daniel Koller, PhD; Femke van’t Hof, MD; Mitja I. Kurki, PhD; Craig S. Anderson, MD; Robert D. Brown Jr, MD; Edward Sander Connolly, MD; Johan G. Eriksson, MD; Matthew Flaherty, MD; Myriam Fornage, PhD; Mikael von und zu Fraunberg, MD; Emília I. Gaál, MD, PhD; Aki Laakso, MD, PhD; Juha Hernesniemi, MD, PhD; John Huston, MD; Juha E. Jääskeläinen, MD, PhD; Lambertus A. Kiemeney, PhD; Riku Kivisaari, MD, PhD; Dawn Kleindorfer, MD; Nerissa Ko, MD; Hanna Lehto, MD; Jason Mackey, MD; Irene Meissner, MD; Charles J. Moomaw, PhD; Thomas H. Mosley, PhD; Marek Moskala, MD, PhD; Mika Niemelä, MD, PhD; Aarno Palotie, MD, PhD; Joanna Pera, MD, PhD; Gabriel Rinkel, MD, PhD; Stephan Ripke, MD; Guy Rouleau, MD, PhD; Ynte Ruigrok, MD, PhD; Laura Sauerbeck, MS; Agnieszka Słowik, MD, PhD; Sita H. Vermeulen, PhD; Daniel Woo, MD; Bradford B. Worrall, MD; Joseph Broderick, MD; for the Familial Intracranial Aneurysm Study Investigators

Background and Purpose: Common variants have been identified using genome-wide association studies which contribute to intracranial aneurysms (IA) susceptibility. However, it is clear that the variants identified to date do not account for the estimated genetic contribution to disease risk.

07 octubre 2014

STROKE. Transcranial Laser Therapy in Acute Stroke Treatment. Results of Neurothera Effectiveness and Safety Trial 3, a Phase III Clinical End Point Device Trial

Werner Hacke, MD, PhD; Peter D. Schellinger, MD; Gregory W. Albers, MD; Natan M. Bornstein, MD; Bjorn L. Dahlof, MD; Rachael Fulton, PhD; Scott E. Kasner, MD; Ashfaq Shuaib, MD; Steven P. Richieri, MD; Stephen G. Dilly, MD; Justin Zivin, MD, PhD; Kennedy R. Lees, MD; for the NEST 3 Committees and Investigators

Background and Purpose: On the basis of phase II trials, we considered that transcranial laser therapy could have neuroprotective effects in patients with acute ischemic stroke.

28 agosto 2014

STROKE. Challenges of Acute Endovascular Stroke Trials

Mayank Goyal, MD; Mohammed Almekhlafi, MD, MSc; Bijoy Menon, MD; Michael Hill, MD, MSc; Kyle Fargen, MD, MPH; Mark Parsons, MD; Oh Young Bang, MD, PhD; Adnan Siddiqui, MD; Tommy Andersson, MD, PhD; Vitor Mendes, MD, MSc; Antoni Davalos, MD; Aquilla Turk, MD; J Mocco, MD, MS; Bruce Campbell, MBBS, BMedSc, PhD; Raul Nogueira, MD; Rishi Gupta, MD, MBA, FANA; Sean Murphy, MD; Tudor Jovin, MD; Pooja Khatri, MD, MSc; Zhongrong Miao, MD; Andrew Demchuk, MD; Joseph P. Broderick, MD; Jeffrey Saver, MD

Introduction: Intravenous thrombolytic therapy with tissue-type plasminogen activator (tPA) has been approved for acute ischemic stroke since 1996. However, its tight time window means that many centers only treat a minority of patients. Effectiveness is limited by the low recanalization rates of large intracranial occlusions (4% distal internal carotid and basilar artery and 32%–37% M1 middle cerebral artery),1,2 which has high disability and mortality.3 Clinical outcome at 3 months is strongly associated with the timeliness and extent of reperfusion.4,5 These findings call for therapies beyond intravenous tPA to improve clinical outcomes in such patients.

22 octubre 2015

SPRINGER. Observer variability of absolute and relative thrombus density measurements in patients with acute ischemic stroke

Emilie M. M. Santos, Albert J. Yoo, Ludo F. Beenen, Olvert A. Berkhemer, Mark D. den Blanken, Carrie Wismans, Wiro J. Niessen, Charles B. Majoie, Henk A. Marquering and 1 more

Introduction: Thrombus density may be a predictor for acute ischemic stroke treatment success. However, only limited data on observer variability for thrombus density measurements exist. This study assesses the variability and bias of four common thrombus density measurement methods by expert and non-expert observers.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.